AGECHEM VENTURE FUND
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.
AGECHEM VENTURE FUND
Founded:
2006-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Apache PHP
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-05-15 | Sorbent Therapeutics | AgeChem Venture Fund investment in Series D - Sorbent Therapeutics | 6.5 M USD |
| 2013-11-06 | Aerpio Pharmaceuticals | AgeChem Venture Fund investment in Series A - Aerpio Pharmaceuticals | 36 M USD |
| 2013-06-04 | Akebia Therapeutics | AgeChem Venture Fund investment in Series C - Akebia Therapeutics | 41 M USD |
| 2012-11-02 | Alethia BioTherapeutics | AgeChem Venture Fund investment in Series B - Alethia BioTherapeutics | 4.7 M USD |
| 2011-09-27 | Medicago | AgeChem Venture Fund investment in Post-IPO Equity - Medicago | 25 M CAD |
| 2011-06-30 | Sorbent Therapeutics | AgeChem Venture Fund investment in Series B - Sorbent Therapeutics | 36 M USD |
| 2011-04-26 | Akebia Therapeutics | AgeChem Venture Fund investment in Series B - Akebia Therapeutics | 22 M USD |
| 2011-02-11 | Conatus Pharmaceuticals | AgeChem Venture Fund investment in Series B - Conatus Pharmaceuticals | 20 M USD |
| 2010-09-13 | Sorbent Therapeutics | AgeChem Venture Fund investment in Series B - Sorbent Therapeutics | 21.8 M USD |
| 2010-09-07 | Alethia BioTherapeutics | AgeChem Venture Fund investment in Series A - Alethia BioTherapeutics | 9.2 M USD |
More informations about "AgeChem Venture Fund"
AgeChem - Financing the medecines of tomorrow
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies …See details»
AgeChem - Financing the medecines of tomorrow
The principals at AgeChem have operational experience having been involved in the launching of companies, their financing and in the management of their growth and liquidity event. ... Dr. …See details»
GeneChem - Agechem Venture Fund - About Us
In 2006, GeneChem raised its third focused fund to capitalise on the growth of the aging "Baby Boomer" segment of the population. With committed capital of $65M, the AgeChem Venture …See details»
GeneChem
GeneChem is a manager of specialised biotechnology venture capital funds which include AmorChem, AgeChem, GeneChem Technologies and GeneChem Therapeutics. 1 Westmount Square, Suite 800, Montreal, Quebec, H3Z 2P9 ...See details»
AgeChem Venture Fund - Investments, Portfolio & Company Exits
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting. ... AgeChem Venture Fund has made 2 diversity …See details»
AgeChem Venture Fund: Performance - PitchBook
Dec 31, 2006 AgeChem Venture Fund is a venture capital fund managed by AgeChem Financial. The fund is located in Montreal, Canada, and invested in the United States and …See details»
AgeChem Venture Fund - CoBee Company Profile & Funding …
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem …See details»
GeneChem - Agechem Venture Fund - Portfolio
1 Westmount Square, Suite 800 Montreal, Quebec H3Z 2P9 Canada. T 514-849-7696 F 514-849-5191 [email protected]See details»
AgeChem Venture Fund — 16 Investments, 5 Exits, 11 Portfolio …
Opposing the other organizations, this AgeChem Venture Fund works on 4 percentage points more the average amount of lead investments. The typical case for the fund is to invest in …See details»
AgeChem Financial Investor Profile: Portfolio & Exits - PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for AgeChem Financial. Use the PitchBook Platform to explore the full profile. ...See details»
AgeChem Venture Fund - Updates, News, Events, Signals & Triggers
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targetingSee details»
AgeChem Portfolio Investments, AgeChem Funds, AgeChem Exits
AgeChem Ventures is the investment arm of AgeChem. Use the CB Insights Platform to explore AgeChem's full profile. Technology Vendors; Recent Research; Newsletter ... ARCH Venture …See details»
AgeChem - Financing the medecines of tomorrow
AgeChem Venture Fund L.P. 1001 De Maisonneuve Blvd, West Suite 920 Montreal, Quebec H3A 3C8 T (514) 849-7696 F (514) 849-5191 E [email protected]See details»
AgeChem Venture Fund - BioCentury Company Profiles - BCIQ
AgeChem Venture Fund - BioCentury Company Profiles for the biopharma industrySee details»
AgeChem Venture Fund - CB Insights
AgeChem Venture Fund runs a venture capital firm. Use the CB Insights Platform to explore AgeChem Venture Fund's full profile.See details»
AgeChem Venture Fund - Contacts, Employees, Board Members
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting. Search Crunchbase. ... AgeChem Venture Fund …See details»
Alethia Biotherapeutics Closes C$9.6M Series A Round of Financing
Sep 7, 2010 Alethia Biotherapeutics Inc., a developer of monoclonal antibodies for the treatment and prevention of severe bone loss, ovarian cancer and metastatic breast cancer, closed a …See details»
Alethia Biotherapeutics - VentureRadar
Alethia develops monoclonal antibody therapeutics to novel clinically relevant targets identified using its patented STAR discovery technology. BDC Capital and Go Capital provided seed …See details»
AgeChem Venture Fund - Tech Stack, Apps, Patents & Trademarks …
AgeChem Venture Fund is actively using 2 technologies for its website, according to BuiltWith. These include Apache and PHP. UNLOCK PREMIUM DATA WITH DATABOOST IT Spend by …See details»